LivaNova LIVN Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net revenue by Business | ||||||
| Cardiopulmonary | $208.66M+1.0% | $206.58M+1.7% | $203.22M+2.0% | $199.27M+13.0% | $176.32M-2.9% | |
| Neuromodulation | $151.79M-0.6% | $152.72M+2.1% | $149.53M-1.4% | $151.67M+9.2% | $138.89M+0.9% | |
| Net revenue by Geography | ||||||
| Europe | $75.65M+0.8% | $75.02M+10.8% | $67.68M+1.4% | $66.78M+11.9% | $59.7M-3.1% | |
| Rest of World | $101.93M+8.0% | $94.42M-5.2% | $99.62M+2.4% | $97.27M+10.6% | $87.99M+3.4% | |
| United States | $184.68M-3.6% | $191.49M+0.5% | $190.45M+1.0% | $188.47M+11.4% | $169.16M-3.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does LivaNova break its business down?
- LivaNova (LIVN) reports net revenue by business across 2 parts — Cardiopulmonary and Neuromodulation. Each is extracted from the segment footnotes and tracked over time.
- Where does LivaNova's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in LivaNova's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.